H2020HORIZONFP7
Eurordis - Rare Diseases Europe
- Country
- FRFrance
- Defence projects
- 0
- Projects, all programmes
- 23
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 8,490,791
- Active
- 2012 to 2025
Projects
23 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| PERIFORMANCEPUBLIC ENGAGEMENT IN RESEARCH INFRASTRUCTURES FOR MISSION CANCER: MANAGING COMPLEXITY OF EMERGING TECHNOLOGIES | HORIZON | 2025 | Participant | EUR 20,000 |
| RealiseDComprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases | HORIZON | 2025 | Participant | EUR 505,000 |
| JOIN4ATMPMAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY MEDICINAL PRODUCT DEVELOPMENT AND IMPLEMENTATION FOR PATIENT AND SOCIETY BENEFIT | HORIZON | 2024 | Participant | EUR 102,188 |
| ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCE | HORIZON | 2024 | Participant | EUR 811,033 |
| More-EUROPAMore Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making | HORIZON | 2023 | Participant | EUR 64,375 |
| MMMMedicine Made to Measure. | HORIZON | 2023 | Associated partner | EUR 0 |
| FACILITATEFrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem | H2020 | 2022 | Participant | EUR 140,250 |
| REMEDi4ALLBUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL | HORIZON | 2022 | Participant | EUR 1,388,725 |
| SCREEN4CAREShortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies | H2020 | 2021 | Participant | EUR 736,895 |
| ERICAEuropean Rare dIsease research Coordination and support Action | H2020 | 2021 | Participant | EUR 143,675 |
| HTxNext Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe | H2020 | 2019 | Participant | EUR 625,908 |
| EJP RDEuropean Joint Programme on Rare Diseases | H2020 | 2019 | Participant | EUR 941,764 |
| Solve-RDSolving the unsolved Rare Diseases | H2020 | 2018 | Participant | EUR 375,000 |
| PARADIGMPatients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. | H2020 | 2018 | Participant | EUR 463,598 |
| c4cconect4children (COllaborative Network for European Clinical Trials For Children) | H2020 | 2018 | Participant | EUR 653,750 |
| AEGISAccelerated Early staGe drug diScovery | H2020 | 2016 | Partner | EUR 0 |
| GCOFA stepping stone approach towards the Genetics Clinic of the Future | H2020 | 2015 | Participant | EUR 72,544 |
| ADAPT-SMARTAccelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890 | H2020 | 2015 | Participant | EUR 78,000 |
| WEB-RADRRecognising Adverse Drug Reactions | FP7 | 2014 | Participant | EUR 80,475 |
| RARE-BESTPRACTICESPlatform for sharing best practices for management of rare diseases | FP7 | 2013 | Participant | EUR 168,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.